Trials / Unknown
UnknownNCT05070884
Clinical Validation of Radiomics Artificial Intelligence: Application to Breast Cancer Treatment Planning
Clinical Validation of Radiomics Artificial Intelligence: Application to Breast Cancer
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 5,000 (estimated)
- Sponsor
- Instituto de Investigacion Sanitaria La Fe · Academic / Other
- Sex
- Female
- Age
- 18 Years – 85 Years
- Healthy volunteers
- —
Summary
RadioVal will develop and implement interoperable solutions for clinical deployment of the radiomics tools, including information, training, and communication packages for clinicians and patients, as well as standard operating procedures for the integration of radiomics in clinical oncology. With this study, we will clinically validate these solutions, by looking at their reliability for precise breast cancer diagnosis, treatment recommendation and prognosis estimate, treatment response, evaluation of residual disease and outcome prediction.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | The development of new clinical AI solutions to predict treatment response to neoadjuvant chemotherapy (NAC) in breast cancer | Evaluate response to neoadjuvant treatment in advanced breast cancer |
Timeline
- Start date
- 2023-06-01
- Primary completion
- 2025-08-01
- Completion
- 2025-12-01
- First posted
- 2021-10-07
- Last updated
- 2023-02-03
Locations
8 sites across 8 countries: Argentina, Austria, Croatia, Egypt, Poland, Spain, Sweden, Turkey (Türkiye)
Source: ClinicalTrials.gov record NCT05070884. Inclusion in this directory is not an endorsement.